Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
IMRX · NASDAQ · Pharmaceutical Preparations
Immuneering (IMRX) · oqro.io/stocks/IMRX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$3.52−0.19 (−5.12%)
Close of Nov 16, 2026, vs Nov 13 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
CFO purchased ~$90K of IMRX shares in the open marketSourceInsider trade · Traded Jun 23, 2026 · Filed Jun 24, 2026
CEO purchased ~$11K of IMRX shares in the open marketSourceInsider trade · Traded Jun 15, 2026 · Filed Jun 16, 2026
Officer purchased ~$25K of IMRX shares in the open marketSourceInsider trade · Traded Jan 16, 2026 · Filed Jan 21, 2026
Officer purchased ~$25K of IMRX shares in the open marketSourceInsider trade · Traded Jan 15, 2026 · Filed Jan 20, 2026
Director purchased ~$101K of IMRX shares in the open marketSourceInsider trade · Traded Jan 15, 2026 · Filed Jan 16, 2026
Officer purchased ~$11K of IMRX shares in the open marketSourceInsider trade · Traded Jan 13, 2026 · Filed Jan 15, 2026
Officer purchased ~$11K of IMRX shares in the open marketSourceInsider trade · Traded Jan 12, 2026 · Filed Jan 14, 2026
Director purchased ~$87K of IMRX shares in the open marketSourceInsider trade · Traded Oct 3, 2025 · Filed Oct 7, 2025
Director purchased ~$50K of IMRX shares in the open marketSourceInsider trade · Traded Sep 29, 2025 · Filed Sep 30, 2025
Director purchased ~$36K of IMRX shares in the open marketSourceInsider trade · Traded Jul 2, 2025 · Filed Jul 7, 2025
Officer purchased ~$2.5K of IMRX shares in the open marketSourceInsider trade · Traded Jul 2, 2025 · Filed Jul 7, 2025
Director purchased ~$11K of IMRX shares in the open marketSourceInsider trade · Traded Jul 2, 2025 · Filed Jul 7, 2025
Director purchased ~$9K of IMRX shares in the open marketSourceInsider trade · Traded Jul 2, 2025 · Filed Jul 3, 2025
CEO purchased ~$25K of IMRX shares in the open marketSourceInsider trade · Traded Jun 27, 2025 · Filed Jun 30, 2025
Director purchased ~$35K of IMRX shares in the open marketSourceInsider trade · Traded Jun 20, 2025 · Filed Jun 24, 2025
Officer purchased ~$4.8K of IMRX shares in the open marketSourceInsider trade · Traded Jun 20, 2025 · Filed Jun 24, 2025
Officer purchased ~$20K of IMRX shares in the open marketSourceInsider trade · Traded Jun 23, 2025 · Filed Jun 24, 2025
Officer purchased ~$15K of IMRX shares in the open marketSourceInsider trade · Traded Jul 1, 2025 · Filed Jul 3, 2025
CEO purchased ~$10K of IMRX shares in the open marketSourceInsider trade · Traded Jun 18, 2025 · Filed Jun 23, 2025
Director purchased ~$63K of IMRX shares in the open marketSourceInsider trade · Traded Jun 18, 2025 · Filed Jun 20, 2025
CEO purchased ~$50K of IMRX shares in the open marketSourceInsider trade · Traded Jun 17, 2025 · Filed Jun 18, 2025
Director purchased ~$89K of IMRX shares in the open marketSource